The main objective of this study is to compare two post-stroke/TIA (transient ischemic attack) imaging strategies in terms of the number of clinically important (i.e. requiring specific treatment according to current recommendations) lesions detected. The first strategy is the current/usual strategy in each participating centre and the second strategy consists in starting the post-stroke/TIA imaging assessment by a whole-body, low-dose angiography and subsequently resorting to elements of the usual strategy if required.
The patient was informed about the implementation of the study, its objectives, constraints and patient rights
The patient has given free and informed consent and signed the consent
Patient affiliated with or beneficiary of a health insurance plan
Patient available for 36 months of follow-up
The patient is currently participating in or has participated in another biomedical research study within the past three months or is currently in an exclusion period determined by a previous study.
Patient under guardianship or judicial protection
Refusal to sign the consent
Inability to correctly inform the patient or his/her trusted person about the study